Abdellatif, Mahmoud http://orcid.org/0000-0002-5042-9054
Rainer, Peter P. http://orcid.org/0000-0002-2840-6454
Sedej, Simon
Kroemer, Guido http://orcid.org/0000-0002-9334-4405
Article History
Accepted: 21 April 2023
First Online: 16 May 2023
Competing interests
: M.A. and S.S. are involved in patent applications related to the cardiometabolic effects of caloric restriction mimetics. G.K. holds research contracts with Daiichi Sankyo, Eleor, Kaleido, Lytix Pharma, Osasuna Therapeutics, PharmaMar, Samsara Therapeutics, Sanofi, Tollys and Vascage. G.K. is a consultant for Reithera and is on the Board of Directors of the Bristol Myers Squibb Foundation, France. G.K. is also a scientific co-founder of everImmune, Osasuna Therapeutics, Samsara Therapeutics and Therafast Bio. G.K. is the inventor of patents covering therapeutic targeting of ageing, cancer, cystic fibrosis and metabolic disorders. G.K.’s wife, Laurence Zitvogel, has held research contracts with 9 Meters Biopharma, Daiichi Sankyo and Pilege, was on the Board of Directors of Transgene, is a co-founder of everImmune, and holds patents covering the treatment of cancer and therapeutic manipulation of the microbiota. G.K.’s brother, Romano Kroemer, was an employee of Sanofi and consulted for Boehringer-Ingelheim. P.P.R. declares no competing interests.